Pharmacist’s recommendations of over-the-counter treatments for the common cold - analysis of prospective cases in Poland

Abstract

Background Common cold is a frequent illness in northern hemisphere between late autumn and early spring. Patients suffering from it frequently turn to pharmacists instead of physicians in order to receive medical advice and treatment. We studied its treatment advised by pharmacists in Poland, as well as evidence for the efficacy of their recommendations by utilizing a self-developed questionnaire and a study of existing literature. Methods The data were collected by 27 pharmacists who worked in four large network community pharmacies in Lodz, Poland. The study took place from December 2019 to February 2020. Data were recorded only if the patient asked for pharmacy counselling for over-the counter (OTC) products due to common cold self-diagnosis and a product was sold. Pharmacists’ recommendations were compared with the results of a literature review of best evidence to determine appropriateness of the pharmacists’ decisions. Results In four out of five cases the pharmacists recommended products contained paracetamol. In addition, in one out of three patient encounters they advised nasal decongestant, inosines and/or OTC mucolytics. There was a significant relationship between fever and recommendation frequency of some analgesics, inosines, mucolytics and sore throat products (OR > 1, p < 0.05); rhinorrhea and recommendation frequency of paracetamol, inosines, anti-histamines and alpha-mimetics (OR > 1, p < 0.05); cough and recommendation frequency of paracetamol, inosines, mucolytics and sore throat products (OR > 1, p < 0.05); and fatigue and recommendation frequency of paracetamol, acetylsalicylic acid, inosines and sore throat products (OR > 1, p < 0.05). The pharmacist recommendations were based on patients’ symptoms, product price, pharmaceutical company promotion and the financial incentive. In many cases their recommendations were not in line with current best practice recommendations. Conclusions Our study suggests that the most common rationale for pharmacist recommendation on anti-common cold treatment was to take a “shotgun” approach. Pharmacists commonly made recommendations for products that lack strong evidence for efficacy (i.e. anti-viral agents) and are potentially unnecessary, based on presentation of the symptom. Reasons for this situation include lack of training, lack of time to evaluate the patient, lack of awareness of evidence as well as drug company marketing and financial incentives (i.e. fulfilling sale plans and target sale bonuses). Trial registration The study was a non-interventional, observational research trial. The study registration was not required.

Euphorbium compositum SN improves the innate defenses of the airway mucosal barrier network during rhinovirus infection

“…Common colds cause discomfort, and the affected people more often resort to over-the-counter medication even if they are not proven to be very effective [30][31][32]. Common colds caused by RV are associated with upper respiratory symptoms including runny nose, sore throat and sometimes fever.…”

Effect of andrographolide and deep eutectic solvent extracts of Andrographis paniculata on human coronavirus organ culture 43 (HCoV-OC43)

“…Colds and associated symptoms are commonly caused by coronaviruses, such as infections with non-severe acute respiratory syndrome (non-SARS)-related viruses or severe acute respiratory syndrome (SARS) coronaviruses ( Calvo et al, 2020 ; Liu et al, 2021 ). The majority of cold patients with mild symptoms are commonly treated with supportive treatments such as nonsteroidal anti-inflammatory drugs, antihistamines, mucolytics, cough suppressants, and/or complementary medicines ( Pietrusiewicz et al, 2021 ; Hui et al, 2022 ). To prevent severe symptoms of coronavirus infection, repurposing antiviral drugs has been an interesting strategy for the treatment of viral infections such as COVID-19, although their efficacy remains unclear (Martinez, 2022).…”

Self-efficacy of community pharmacists and associated factors in counselling to support self-medication in Japan: A crosssectional study

“…When pharmacists recommend OTC, there are cases where these do not follow the recommendations of best practices. 16 Furthermore, pharmacists have learning needs related to evidence based practice (EBP). 17 Pharmacists also need to be aware of the value of counseling regarding OTC use as it plays an important role in encouraging consultation.…”